Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 6/20 | 0.38 |
| ▸ | DRD3 | P35462 | 6/20 | 0.38 |
| ▸ | HTR1A | P08908 | 5/20 | 0.34 |
| ▸ | HTR7 | P34969 | 5/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HTR1D | P28221 | 1/20 | 0.33 |
| ▸ | HTR1B | P28222 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14525551 | 0.84 | DRD2 (0.42) | CYP2A6ALDH1A1CYP2A13TSHRDRD2 | |
| SCHEMBL18534019 | 0.83 | ACHE (0.31) | DRD2DRD3 | |
| SCHEMBL14525565 | 0.81 | HTR2A (0.42) | CYP2A6ALDH1A1CYP2A13TSHRDRD2 | |
| SCHEMBL19032997 | 0.79 | ALDH1A1 (0.42) | CYP2A6ALDH1A1CYP2A13TSHRDRD2 | |
| SCHEMBL12511860 | 0.79 | ALDH1A1 (0.42) | CYP2A6ALDH1A1CYP2A13TSHRDRD2 | |
| SCHEMBL24718000 | 0.79 | ALDH1A1 (0.42) | CYP2A6ALDH1A1CYP2A13TSHRDRD2 | |
| SCHEMBL23510011 | 0.79 | ALDH1A1 (0.42) | CYP2A6ALDH1A1CYP2A13TSHRDRD2 | |
| SCHEMBL14525577 | 0.78 | TRPV1 (0.37) | DRD2DRD3HTR1AHTR7HTR1D | |
| SCHEMBL12433434 | 0.78 | CYP2A6 (0.39) | CYP2A6ALDH1A1CYP2A13TSHRDRD2 | |
| SCHEMBL12433436 | 0.78 | ALDH1A1 (0.39) | CYP2A6ALDH1A1CYP2A13TSHRDRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228878-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME | DIC CORPORATION (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240228878-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME | DIC CORPORATION (JP) | 2024-07-11 | — | — | US | disclosed |
| US-10662378-B2 | Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2020-05-26 | — | — | US | disclosed |
| US-10570334-B2 | Liquid crystal compound, liquid crystal composition, composite material with encapsulated liquid crystal, and liquid crystal display device using same | JNC CORPORATION (JP) | 2020-02-25 | — | — | US | disclosed |
| US-20200032143-A1 | COMPOUND HAVING DIBENZOFURAN RING, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORPORATION (JP) | 2020-01-30 | — | — | US | disclosed |
| US-10428273-B2 | Liquid crystal compound having benzopyran skeleton, liquid crystal composition, and liquid crystal display device | JNC CORPORATION (JP) | 2019-10-01 | — | — | US | disclosed |
| US-10323187-B2 | Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2019-06-18 | — | — | US | disclosed |
| US-10208249-B2 | Liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2019-02-19 | — | — | US | disclosed |
| US-20180119009-A1 | LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-05-03 | — | — | US | disclosed |
| US-20180119009-A1 | LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-05-03 | — | — | US | disclosed |
| US-20070187644-A1 | Liquid crystal compound, liquid crystal composition, and liquid crystal display device | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2007-08-16 | — | — | US | disclosed |
| US-20070187644-A1 | Liquid crystal compound, liquid crystal composition, and liquid crystal display device | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2007-08-16 | — | — | US | disclosed |
| US-7232592-B2 | Compounds having a 4,6-difluoroindan-2,5-diyl group; composition of up to 6 compounds gives good response speed, good electrooptical liquid crystal display, matrix liquid crystal display elements | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2007-06-19 | — | — | US | disclosed |
| US-7232592-B2 | Compounds having a 4,6-difluoroindan-2,5-diyl group; composition of up to 6 compounds gives good response speed, good electrooptical liquid crystal display, matrix liquid crystal display elements | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2007-06-19 | — | — | US | disclosed |
| US-7198827-B1 | Nematic liquid crystal composition and liquid crystal display device using the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2007-04-03 | — | — | US | disclosed |
| US-7198827-B1 | Nematic liquid crystal composition and liquid crystal display device using the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2007-04-03 | — | — | US | disclosed |
| US-7195719-B1 | High polarization ferroelectric liquid crystal compositions | DISPLAYTECH, INC. (US) | 2007-03-27 | — | — | US | disclosed |
| US-7195719-B1 | High polarization ferroelectric liquid crystal compositions | DISPLAYTECH, INC. (US) | 2007-03-27 | — | — | US | disclosed |
| US-7157124-B2 | Polymerizable compounds and their polymers | CHISSO PETROCHEMICAL CORPORATION (JP) | 2007-01-02 | — | — | US | disclosed |
| US-7157124-B2 | Polymerizable compounds and their polymers | CHISSO PETROCHEMICAL CORPORATION (JP) | 2007-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180119009-A1 | LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | YBX1, PIEZO1, C1S | CYP2A6 2050/4885ALDH1A1 1182/4885CYP2A13 658/4885 |
| US-10570334-B2 | Liquid crystal compound, liquid crystal composition, composite material with encapsulated liquid crystal, and liquid crystal display device using same | SOD1, SLC39A11, MTX1 | CYP2A6 2507/4885ALDH1A1 688/4885CYP2A13 2135/4885 |
| US-10428273-B2 | Liquid crystal compound having benzopyran skeleton, liquid crystal composition, and liquid crystal display device | PIEZO1, PYCARD, NLRP1 | CYP2A6 2619/4885ALDH1A1 2282/4885CYP2A13 2162/4885 |
| US-10323187-B2 | Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device | YBX1, PIEZO1, C1S | CYP2A6 2050/4885ALDH1A1 1182/4885CYP2A13 658/4885 |
| US-10662378-B2 | Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device | YBX1, ZKSCAN2, RCC1 | CYP2A6 2140/4885ALDH1A1 577/4885CYP2A13 954/4885 |
| US-20240228878-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME | TTI2, CCT4, CCT2 | CYP2A6 4709/4885ALDH1A1 4223/4885CYP2A13 4700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.